window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 14, 2025

  • News
  • About Us
Contact Us

Patient Outcomes

  • CDMOs & Manufacturing,Global health,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Lungpacer receives CMS NTAP approval for AeroPace system, enhancing care for mechanically ventilated patients

    Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

    August 15, 2025
  • Artificial Intelligence,Data Management,Patient Centricity,Precision medicine,Real world evidence,Research & Development

    OMNY Health dataset surpasses 100M patients, creating largest US repository of unstructured clinical data

    OMNY Health has reached a major milestone, announcing that its [...]

    July 31, 2025
  • Biologics & Biosimilars,Clinical Development,Patient Centricity,Regulatory Affairs

    NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure

    Mirikizumab is now recommended by NICE for routine NHS use [...]

    July 14, 2025
  • Clinical Trials,Drug Development,Regulatory Affairs

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 30, 2025
  • Artificial Intelligence

    ICU level care not definitive indicator for sepsis, new study shows

    April 22, 2025
  • Drug Delivery & Formulation

    FDA approves compassionate use of reverse hip replacement system for spinal fusion patients

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top